CONTRIBUTION OF ORAL MAGNETIC PARTICLES IN MR IMAGING OF THE ABDOMEN WITH SPIN-ECHO AND GRADIENT-ECHO SEQUENCES

被引:15
作者
BOUDGHENE, FP
BACHGANSMO, T
GRANGE, JD
LAME, S
NANTOIS, C
WALLAYS, C
BIGOT, JM
机构
[1] Departments of Radiology Hopital Tenon, Paris, F-75020
[2] Departments of Gastroenterology Hǒpital Tenon, Paris, F-75020
[3] Departments of Nycomed Imaging, Oslo
来源
JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING | 1993年 / 3卷 / 01期
关键词
ABDOMEN; MR; CONTRAST ENHANCEMENT; CONTRAST MEDIA; GASTROINTESTINAL TRACT; IRON; SAFETY;
D O I
10.1002/jmri.1880030118
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
An open phase III clinical trial of the oral contrast agent OMP (oral magnetic particles) was performed in 35 patients undergoing abdominal magnetic resonance (MR) imaging at 1.5 T with axial spin-echo and gradient-echo sequences. The diagnostic efficacy of OMP was examined by comparing pre- and postcontrast images. Bowel loops and abdominal organs were more easily recognizable after OMP ingestion, and the general quality of the images was improved because of fewer bowel-related artifacts. The diagnostic value of the postcontrast abdominal MR examination was superior or equal to that of the precontrast study, and additional information was obtained in 44% of the cases. Postcontrast gradient-echo sequences increased confidence in the MR examination in 18% of cases. OMP was well tolerated and increased the quality and amount of diagnostic information acquired during the examination. Gradient-echo imaging was found to be a useful complement, but the need for a reduction in susceptibility artifacts was apparent and indicates that a decrease in TE or the use of rapid spin-echo sequences might be advantageous.
引用
收藏
页码:107 / 112
页数:6
相关论文
共 34 条
[1]  
Liver imaging: current trends and new techniques, (1990)
[2]  
Chezmar JL, Rumancik WM, Megibow AJ, Hulnick DH, Nelson RC, Bernardino ME, Liver and abdominal screening in patients with cancer: CT versus MR imaging, Radiology, 168, pp. 43-47, (1988)
[3]  
Wesbey GE, Brasch RC, Engelstad BL, Moss AA, Crooks LE, Brito AC, Nuclear magnetic resonance contrast enhancement study of the gastrointestinal tract of rats and a human volunteer using nontoxic oral iron solutions, Radiology, 149, pp. 175-180, (1983)
[4]  
Hahn PF, Stark DD, Saini S, Lewis JM, Wittenberg J, Ferrucci JT, Ferrite particles for bowel contrast in MR Imaging: design issues and feasibility studies, Radiology, 164, pp. 37-41, (1987)
[5]  
Laniado M, Kornmesser W, Hamm B, Clauss W, Weinmann HJ, Felix R, MR imaging of the gastrointestinal tract: value of Gd‐DTPA, AJR, 150, pp. 817-821, (1988)
[6]  
Lonnemark M, Hemmingsson A, Carlsten J, Ericsson A, Holtz E, Klaveness J, Superparamagnetic particles as an MRI contrast agent for the gastrointestinal tract, Acta Radiologica, 29, pp. 599-602, (1988)
[7]  
Wesbey GE, Brasch RC, Goldberg HI, Engelstad BL, Moss AA, Dilute oral iron solutions as gastrointestinal contrast agents for magnetic resonance imaging: initial clinical experience, Magn Reson Imaging, 3, pp. 57-64, (1985)
[8]  
Widder DJ, Edelman RR, Grief WL, Monda L, Magnetite albumin suspension: a Superparamagnetic oral MR contrast agent, AJR, 149, pp. 839-843, (1987)
[9]  
Kaminski S, Laniado M, Gogoll M, Et al., Gadopentetate dimeglumine as a bowel contrast agent: safety and efficacy, Radiology, 178, pp. 503-508, (1991)
[10]  
Gore C, Majumdar S, Superparamagnetic iron oxide particles, Radiology, 169, pp. 657-658, (1988)